Joint replacement implant maker Conformis (NSDQ:CFMS) announced that it appointed Farzin Kaghani as its new VP of U.S. marketing.
Khaghani, a veteran of more than 20 years in orthopedic and medtech sales and marketing, most recently served as president at NextStep Arthropedix, but before that, he spent more than 10 years at Conformis in a number of roles.
According to a news release, Khaghani also served as product director at Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes for five years. Before that, he served as director of operations at Win Enterprises.
“We are very pleased to announce that Farzin Khaghani has rejoined our team as VP, U.S. marketing,” Conformis president & CEO Mark Augusti said in the release. “Farzin’s product expertise and track record of successfully supporting strategic goals and attracting new surgeon users to the Conformis family will help us continue our successful market expansion. I look forward to the contributions Farzin will make as a member of Conformis’ team.”
Khaghani was also granted a stock option to purchase 100,000 shares of Conformis’ common stock, along with a restricted stock unit award of 100,000 shares of common stock.